SCHEMBL16356699

SCHEMBL16356699

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-n5c6ccc7ccccc7c6c6c7ccccc7ccc65)cc4)cc3)c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MAPT P10636 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HDAC4 P56524 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ ABCG2 Q9UNQ0 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22901144 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL16356684 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL16356700 0.99 ATM (0.37) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL15138525 0.99 L3MBTL1 (0.37) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL13932506 0.99 L3MBTL1 (0.37) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL16356704 0.99 L3MBTL1 (0.37) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL19507399 0.99 ATM (0.37) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL13932486 0.94 L3MBTL1 (0.40) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL17742538 0.94 CDK4 (0.32) KDM4EL3MBTL1ATMCYP1A2ABCG2
SCHEMBL24374268 0.93 L3MBTL1 (0.40) KDM4EL3MBTL1ATMMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-07-17 — — US disclosed
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-07-17 — — US disclosed
US-20140374722-A1 COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2014-12-25 — — US disclosed
US-20140374722-A1 COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof ORAI2, TMEM109, EML4 KDM4E 1695/4885L3MBTL1 749/4885ATM 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback